Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2017 Filed Feb 8, 2017 00:17 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantStock Appreciation Right · Derivative | 5,510 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-008463 · doc4.xml · derivative · entry 6 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,510 Underlying: Common Stock · 5,510 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 2,750 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 12 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 Underlying: Common Stock · 2,750 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F9 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 3,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 11 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 3,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 10 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2014 and 2015 was met, resulting in the vesting of 3,500 stock appreciation rights. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 6,375 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 9 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 Underlying: Common Stock · 6,375 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 6, 2014. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 6,375 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 8 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,375 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2013, 2014 and 2015 was met, resulting in the vesting of 6,375 stock appreciation rights. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 7 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · derivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Tax withholdingCommon Stock | 26,599 | $80.93 | $2,152,657.07 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · nonDerivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,148.0531 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionCommon Stock | 2,750 | $68.96 | $189,640.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · nonDerivative · entry 4 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,747.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionCommon Stock | 7,000 | $47.97 | $335,790.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,997.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionCommon Stock | 12,750 | $37.18 | $474,045.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,997.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionCommon Stock | 20,000 | $22.95 | $459,000.00 |
DisclosureSEC source: 0001209191-17-004684 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,247.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-004682 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,900 Underlying: Common Stock · 2,150 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 2,150 | $80.00 | $172,000.00 |
DisclosureSEC source: 0001209191-17-004682 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,586.0681 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:55 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 2,150 | $17.33 | $37,259.50 |
DisclosureSEC source: 0001209191-17-004682 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,736.0681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 01:14 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,300 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-003447 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,050 Underlying: Common Stock · 4,300 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 01:14 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 4,300 | $78.00 | $335,400.00 |
DisclosureSEC source: 0001209191-17-003447 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,586.0681 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,054.0681 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 01:14 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 4,300 | $17.33 | $74,519.00 |
DisclosureSEC source: 0001209191-17-003447 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,886.0681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,054.0681 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · derivative · entry 9 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · derivative · entry 8 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · derivative · entry 7 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · derivative · entry 6 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in equal increments at the end of fiscal years 2012, 2013 and 2014 upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
SaleCommon Stock | 97,500 | $74.90 | $7,302,750.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · nonDerivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.705 to $75.10, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 10,000 | $22.10 | $221,000.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 12,500 | $21.35 | $266,875.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 23:53 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 75,000 | $17.33 | $1,299,750.00 |
DisclosureSEC source: 0001209191-16-151500 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Feb 14, 2017 22:52 UTC |
Elcan Patricia F10% owner
|
GiftCommon Stock, par value $0.01 per share | 8,922.5988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010681 · doc5.xml · nonDerivative · entry 7 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly by GRATs Disclosed balance after: 1,061,920.6176 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. On September 23, 2016, Hercules Holding II, LLC, a Delaware limited liability company, was converted into Hercules Holding II, a Delaware general partnership. F4 · ownership.nature: The Reporting Person is the trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's husband is the trustee of six grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate of 35,190 shares of common stock of HCA Holdings, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 1,026,730.6176 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. F6 · ownership.nature: On November 17, 2016, The Patricia Frist Elcan 2014 Annuity Trust VI transferred an aggregate of 8,922.5988 units of Hercules to three trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2014 Annuity Trust VI, and the Reporting Person's husband is trustee of the three trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| November 17, 2016 Filed Feb 14, 2017 22:52 UTC |
Elcan Patricia F10% owner
|
GiftCommon Stock, par value $0.01 per share | 8,922.5988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010681 · doc5.xml · nonDerivative · entry 6 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by The Patricia Frist Elcan 2014 Annuity Trust VI Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. On September 23, 2016, Hercules Holding II, LLC, a Delaware limited liability company, was converted into Hercules Holding II, a Delaware general partnership. F6 · ownership.nature: On November 17, 2016, The Patricia Frist Elcan 2014 Annuity Trust VI transferred an aggregate of 8,922.5988 units of Hercules to three trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2014 Annuity Trust VI, and the Reporting Person's husband is trustee of the three trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 6 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Indirect · By TCM Trust (Spouse, Trustee) Disclosed balance after: 8,489 Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 5 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,081 Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 4 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Indirect · By MRM Trust (Spouse, Trustee) Disclosed balance after: 12,435 Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 3 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,831 Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Indirect · By MAM Trust (Spouse, Trustee) Disclosed balance after: 8,489 Read SEC document |
| November 16, 2016 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GiftCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,581 Read SEC document |
| November 10, 2016 Filed Feb 4, 2017 00:14 UTC |
HAZEN SAMUEL NPresident & COO
|
GiftCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007874 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC 92 Disclosed balance after: 75,000 F1 · kind: On August 17, 2016, the reporting person transferred 75,000 shares to a limited liability company wholly-owned by the reporting person. On November 10, 2016, the reporting person transferred 99% of the membership interests in the limited liability company to a trust, of which reporting person's spouse is trustee. Read SEC document |
| November 10, 2016 Filed Feb 4, 2017 00:14 UTC |
HAZEN SAMUEL NPresident & COO
|
GiftCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007874 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,862 F1 · kind: On August 17, 2016, the reporting person transferred 75,000 shares to a limited liability company wholly-owned by the reporting person. On November 10, 2016, the reporting person transferred 99% of the membership interests in the limited liability company to a trust, of which reporting person's spouse is trustee. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 02:06 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149193 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,374 Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 90,009 | $0.00 Strike: $11.32 | $0.00 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · derivative · entry 13 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,009 shares Expires 2017-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F8 · derivative.exercise_date: The option vested in equal increments at the end of fiscal years 2007, 2008, and 2009 based upon the achievement of certain annual EBITDA performance targets. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 90,009 | $0.00 Strike: $11.32 | $0.00 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · derivative · entry 12 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,009 shares Expires 2017-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on January 30, 2008. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 92,950 | $68.12 | $6,332,032.85 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · nonDerivative · entry 4 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,733 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.58 to $69.02, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 180,018 | $11.32 | $2,037,947.77 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · nonDerivative · entry 3 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 00:13 UTC |
Morgan Sandra L.SVP-Provider Relations
|
SaleCommon Stock | 5,044 | $80.89 | $407,995.04 |
DisclosureSEC source: 0001209191-16-148947 · doc4.xml · nonDerivative · entry 7 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,211.8654 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.8825 to $80.895, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 60,011 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · derivative · entry 11 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,011 shares Expires 2017-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.exercise_date: The option vested in two equal annual installments beginning on January 30, 2011. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,006 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · derivative · entry 10 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,006 shares Expires 2017-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: The option vested in equal increments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 75,017 | $80.50 | $6,038,710.96 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,665 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.90, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 22:56 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 75,017 | $5.31 | $398,145.23 |
DisclosureSEC source: 0001209191-16-149439 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:08 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 788 | $0.00 Strike: $23.13 | $0.00 |
DisclosureSEC source: 0001209191-16-149195 · doc4.xml · derivative · entry 10 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 788 shares Expires 2020-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in two equal installments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:08 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 391 | $0.00 Strike: $23.13 | $0.00 |
DisclosureSEC source: 0001209191-16-149195 · doc4.xml · derivative · entry 9 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 391 shares Expires 2020-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:08 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 392 | $0.00 Strike: $19.11 | $0.00 |
DisclosureSEC source: 0001209191-16-149195 · doc4.xml · derivative · entry 8 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 392 shares Expires 2020-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.